Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups

BIBBINS-DOMINGO, Kirsten a Alex HELMAN. Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups. UNITED STATES: National Academies Press, 2022.

Základní údaje

Originální název

Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups

Autoři

BIBBINS-DOMINGO, Kirsten a Alex HELMAN

Vydání

UNITED STATES, 2022

Nakladatel

National Academies Press

---

Další údaje

Jazyk

angličtina

Typ výsledku

Výzkumná zpráva

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Označené pro přenos do RIV

Ne

Příznaky

Mezinárodní význam

---

Anotace

V originále

The United States has long made substantial investments in clinical research with the goal of improving the health and well-being of our nation. There is no doubt that these investments have contributed significantly to treating and preventing disease and extending human life. Nevertheless, clinical research faces a critical shortcoming. Currently, large swaths of the U.S. population, and those that often face the greatest health challenges, are less able to benefit from these discoveries because they are not adequately represented in clinical research studies. While progress has been made with representation of white women in clinical trials and clinical research, there has been little progress in the last three decades to increase participation of racial and ethnic minority population groups. This underrepresentation is compounding health disparities, with serious consequences for underrepresented groups and for the nation.